Browse > Article

CMV Gastric Ulcers Healed by Supportive Therapy  

Lee, Hyoung-Don (Department of Internal Medicine, Ilsan Paik Hospital, Inje University College of Medicine)
Kim, Nam-Hoon (Department of Internal Medicine, Ilsan Paik Hospital, Inje University College of Medicine)
Lee, Ki-Jun (Department of Internal Medicine, Ilsan Paik Hospital, Inje University College of Medicine)
Lee, Hyuk (Department of Internal Medicine, Ilsan Paik Hospital, Inje University College of Medicine)
Jun, Jin-Ho (Department of Internal Medicine, Ilsan Paik Hospital, Inje University College of Medicine)
Bae, Won-Ki (Department of Internal Medicine, Ilsan Paik Hospital, Inje University College of Medicine)
Kim, Kyung-Ah (Department of Internal Medicine, Ilsan Paik Hospital, Inje University College of Medicine)
Lee, June-Sung (Department of Internal Medicine, Ilsan Paik Hospital, Inje University College of Medicine)
Publication Information
Clinical Endoscopy / v.43, no.1, 2011 , pp. 21-24 More about this Journal
Abstract
Cytomegalovirus (CMV) is a potentially important pathogen in an immunocompromised host. CMV infection usually occurs in patients with severe immune deficiency, such as acquired immunodeficiency syndrome, organ transplantation, malignant disease, or immunosuppressive therapy. CMV can cause ulcerations anywhere in the GI tract ranging from the esophagus to the rectum, but the colon is the most susceptible organ in the GI tract. CMV infection rarely occurs but generally causes an asymptomatic or mildly symptomatic acute illness in immunocompetent patients. Some patients with gastrointestinal CMV disease do not require antiviral treatment such as ganciclovir and frequently recover with supportive therapy. Although in immunocompetent patients, antiviral therapy may be needed based on age, chronic illness, or treatment response. We experienced a case of CMV-induced multiple gastric ulcers with severe epigastric pain in an immunocompetent patient who fully recovered with supportive therapy including a proton pump inhibitor.
Keywords
Cytomegalovirus; Gastric ulcer; Immunocompetent; Supportive therapy;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Craig JM, Macauley JC, Weller TH, Wirth P. Isolation of intranuclear inclusion producing agents from infants illness resembling cytomegalic inclusion disease. Proc Soc Exp Biol 1957;94:4-12.   DOI
2 Goodgame RW. Gastrointestinal cytomegalovirus disease. Ann Intern Med 1993;119:924-935.   DOI   ScienceOn
3 Hinnant KL, Rotterdam HZ, Bell ET, Tapper ML. Cytomegalovirus infection of the alimentary track: a clinic-pathological correlation. Am J Gastroenterol 1986;81:944-950.
4 Ng FH, Chau TN, Cheung TC, et al. Cytomegalovirus colitis in individuals without apparent cause of immunodeficiency. Dig Dis Sci 1999;44:945-952.   DOI   ScienceOn
5 Grundy JE. Virologic and pathogenetic aspects of cytomegalovirus infection. Rev Infect Dis 1990;12(suppl):711S-719S.   DOI
6 Merigan TC, Resta S. Cytomegalovirus: where have we been and where are we going? Rev Infect Dis 1990;12(suppl):693S-700S.   DOI
7 Kaplan CS, Petersen EA, Icenogle TB, et al. Gastrointestinal cytomegalovirus infection in heart and heart-lung transplant recipients. Arch Intern Med 1989;149:2095-2100.   DOI   ScienceOn
8 Bombi JA, Cardesa A, Llebaria C, et al. Main autopsy findings in bone marrow transplant patients. Arch Pathol Lab Med 1987;111:125-129.
9 Foucar E, Mukai K, Foucar K, Sutherland DE, Van Buren CT. Colon ulceration in lethal cytomegalovirus infection. Am J Clin Pathol 1981;76:788-801.   DOI
10 Pasternack MS, Medearis DN Jr, Rubin RH. Cell-mediated immunity in experimental cytomegalovirus infections: a perspective. Rev Infect Dis 1990;12(suppl):720S-726S.   DOI
11 Kim KH, Park BB, Baek HJ, et al. Cytomegalovirus-associated gastritis in immunocompetent adult. Korean J Med 2004;66:326-330.
12 Blanshard C, Benhamou Y, Dohin E, Lernestedt JO, Gazzard BG, Katlama C. Treatment of AIDS-associated gastrointestinal cytomegalovirus infection with foscarnet and ganciclovir: a randomized comparison. J Infect Dis 1995;172:622-628.   DOI   ScienceOn
13 Nelson MR, Connolly GM, Hawkins DA, Gazzard BG. Foscarnet in the treatment of cytomegalovirus infection of the esophagus and colon in patients with the acquired immune deficiency syndrome. Am J Gastroenterol 1991;86:876-881.
14 Markham A, Faulds D. Ganciclovir. An update of its therapeutic use in cytomegalovirus infection. Drugs 1994;48:455-484.   DOI   ScienceOn
15 Wagstaff AJ, Bryson HM. Foscarnet. A reappraisal of its antiviral activity, pharmacokinetics properties and therapeutic use in immunocompromised patients with viral infections. Drugs 1994;48:199-226.   DOI   ScienceOn
16 Eddleston M, Peacock S, Juniper M, Warrell DA. Severe cytomegalovirus infection in immunocompetent patients. Clin Infect Dis 1997;24:52-56.   DOI   ScienceOn
17 Rafailidis PI, Mourtzoukou EG, Varbobitis IC, Falagas ME. Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review. Virol J 2008;5:47.   DOI   ScienceOn
18 Kanno A, Izuma M, Yamada M, Murakami K. Cytomegalovirus- induced gastrointestinal disease in previously healthy adults. Dig Dis Sci 1998;43:746-748.   DOI   ScienceOn